CRISPR Gene Editing Market Insights 2025-2034: Growth Forecast and Strategic Priorities

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

CRISPR Gene Editing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the CRISPR gene editing market has seen impressive expansion. It is predicted to inflate from $2.26 billion in 2024 to approximately $2.88 billion in 2025, presenting a compound annual growth rate (CAGR) of 27.4%. The surge in the historical duration is the result of the growing demand for genome editing strategies, an escalation in government sponsorship, the rising instance of cancer, the increasing pervasiveness of chronic ailments, expanded understanding of CRISPR technology, and improved healthcare facilities.

CRISPR Gene Editing Market Size Forecast: What's the Projected Valuation by 2029?
The market size for CRISPR gene editing is predicted to witness significant growth in the forthcoming years, rising to a value of $7.51 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 27.1%. This anticipated growth during the forecast period can be ascribed to the increasing number of genetic disorders, a greater emphasis on precision medicine, enhanced investment in CRISPR research and development, an upward trend in the geriatric population, and a heightened focus on gene therapy procedures. Key trends expected during this forecast period encompass technological advancements in gene editing, an expansion in research studies, progression in drug discovery and development, innovative delivery methods, and the emergence of CRISPR-edited agriculture.

View the full report here:
https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

What Are the Drivers Transforming the CRISPR Gene Editing Market?
The rise in genetic disorders is anticipated to boost the expansion of the CRISPR gene editing market. Genetic disorders, caused by abnormalities in the genome that could involve a single gene (monogenic), multiple genes (polygenic), or chromosomal abnormalities, are becoming more prevalent due to various factors like genetic mutations, aging populations, and marriages between close relatives. CRISPR gene editing plays a crucial role in handling such disorders by offering precise and focused modifications to the DNA. Scientists are leveraging CRISPR technology to pinpoint and rectify specific mutations responsible for genetic disorders, reinstate normal functionality, and mitigate the symptoms of diseases like cystic fibrosis and sickle cell anemia. For example, the Cystic Fibrosis (CF) Foundation, a US-based non-profit outfit, noted an increase in the cases of people with cystic fibrosis in July 2022. In 2022, nearly 40,000 children and adults in the United States were impacted by cystic fibrosis, with more than 105,000 diagnoses worldwide. This upswing in genetic disorders is, therefore, a key impetus for the growth of the CRISPR gene editing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15549&type=smp

What Long-Term Trends Will Define the Future of the CRISPR Gene Editing Market?
Leading organizations in the CRISPR gene editing industry are concentrating on the creation of novel products like gene therapy to expand their customer reach, enhance sales, and escalate their revenue. Gene therapy applies genes for the prevention, treatment, or potential cure of diseases. For instance, in December 2023, Casgevy, a cell-based gene therapy, was ratified by the US Food and Drug Administration (FDA), a federal agency based in the US, for treating sickle cell disease. CRISPR/Cas9, a specific genome editing technology, is used in Casgevy therapy. This technology modifies hematopoietic stem cells with the use of CRISPR/Cas9.

Which Segments in the CRISPR Gene Editing Market Offer the Most Profit Potential?
The CRISPR gene editing market covered in this report is segmented -

1) By Type: CRISPR-Associated Nuclease (Cas Nuclease), Guide Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA) Ligase, Restriction Endonuclease, Other Types
2) By Services: Design Tools, Plasmid And Vector, CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA), Delivery System Products, Other Services
3) By Technology: CRISPR Or Cas9, Zinc Finger Nucleases, Other Technologies
4) By Application: Agricultural, Biomedical, Industrial, Genome Engineering, Disease Models, Functional Genomics, Other Applications
5) By End User: Academic Institutes And Research Centers, Biotechnology Companies, Contract Research Organizations (CROs), Pharmaceutical And Biopharmaceutical Companies

Subsegments:
1) By CRISPR-Associated Nuclease (Cas Nuclease): Cas9, Cas12, Cas13, Other Cas Nucleases
2) By Guide Ribonucleic Acid (RNA): Single-guide RNA (sgRNA), Dual-guide RNA, Synthetic Guide RNA
3) By Deoxyribonucleic Acid (DNA) Ligase: T4 DNA Ligase, E. coli DNA Ligase, Other DNA Ligases
4) By Restriction Endonuclease: Type II Restriction Enzymes, Type I And III Restriction Enzymes, Other Restriction Enzymes
5) By Other Types: CRISPR Delivery Systems, CRISPR Plasmids, CRISPR-Based Diagnostic Tools

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15549&type=smp

Which Firms Dominate the CRISPR Gene Editing Market by Market Share and Revenue in 2025?
Major companies operating in the CRISPR gene editing market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., GenScript, Integrated DNA Technologies Inc., Takara Bio Inc., OriGene Technologies Inc., Intellia Therapeutics Inc., New England Biolabs, Synthego, Arbor Biotechnologies Inc., Rockland Immunochemicals Inc., Cellectis, Editas Medicine, Caribou Biosciences Inc., System Biosciences LLC, Applied StemCell, Addgene, Mirus Bio LLC, Excision BioTherapeutics Inc., GeneCopoeia Inc., ToolGen Inc., Cellecta Inc., CRISPR Therapeutics, ERS Genomics Limited

Which Regions Offer the Highest Growth Potential in the CRISPR Gene Editing Market?
North America was the largest region in the CRISPR gene editing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15549

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.